AIR.NYSEAar CORP

Form 4: AAR Corp Senior Vice President-CCO, Christopher A. Jessup, Reports Stock Option Exercises and Sales

Sentiment:

SEC Form 4 Filing


Christopher A. Jessup, Senior Vice President-CCO of AAR Corp, executed stock options and sold shares of common stock on May 6, 2024.

Summary

  • On May 6, 2024, Christopher A. Jessup, Senior Vice President-CCO of AAR Corp, exercised stock options to acquire 5,052 shares and 10,877 shares of common stock at exercise prices of $37.74 and $37.66, respectively.
  • Simultaneously, Jessup sold 5,052 shares and 10,877 shares of common stock at a weighted average price of $70.0912.
  • Following these transactions, Jessup directly owns 51,802.525 shares of AAR Corp common stock.
  • The transactions were reported on a Form 4 filed with the SEC on May 8, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions, which carries a neutral sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions provide transparency into the actions of company executives and their holdings in the company's stock.

Comparison to Industry Standards

  • Insider trading activity is a common occurrence in publicly listed companies, and the reporting requirements are standardized by the SEC.
  • Comparable companies such as Boeing, Lockheed Martin, and General Dynamics also have executives who regularly report stock transactions via Form 4 filings.
  • The volume and frequency of these transactions can vary based on individual compensation structures and company performance.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders as they reflect insider trading activity.
  • The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates

DateDescription
January 18, 2023Date of Power of Attorney execution.
July 8, 2019Date of stock option grant for 24,250 shares vesting in increments on July 31, 2020, July 31, 2021, and July 31, 2022.
July 12, 2021Date of stock option grant for 7,580 shares vesting in increments on July 31, 2022, July 31, 2023 and July 31, 2024.
May 6, 2024Date of stock option exercise and sale of common stock.
May 8, 2024Date Form 4 was signed.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.